What is the clinical significance and appropriate management of an RS wave ratio of 1:1 in leads V5 and V6 on an ECG in the context of right bundle branch block (RBBB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

RS Wave Ratio 1:1 in V5 and V6: Clinical Significance and Management

An RS wave ratio of 1:1 in leads V5 and V6 is abnormal and suggests right ventricular hypertrophy or pulmonary hypertension rather than right bundle branch block, as RBBB characteristically shows normal R peak time in V5 and V6 with a dominant R wave (not equal R and S waves). 1

Understanding the Normal Pattern vs. Pathologic Finding

In the context of RBBB, leads V5 and V6 should demonstrate:

  • Normal R peak time (not prolonged) 1
  • Dominant R waves with small S waves - specifically, the S wave should be of greater duration than the R wave or >40 ms in leads I and V6 for RBBB diagnosis 1
  • An RS ratio of 1:1 (equal R and S waves) violates these criteria and indicates a different pathologic process 1

Differential Diagnosis for RS Ratio 1:1 in V5-V6

Primary Consideration: Right Ventricular Hypertrophy/Pulmonary Hypertension

The most likely diagnosis is right ventricular hypertrophy, particularly from pulmonary arterial hypertension, which characteristically produces:

  • Large S wave and small R wave with R/S ratio ≤1 in lead V5 or V6 1
  • Right axis deviation (present in 79% of pulmonary hypertension patients) 1
  • Tall R wave in V1 with R/S ratio ≥1 1
  • S1, S2, S3 pattern 1

This pattern reflects the electrical dominance of the hypertrophied right ventricle extending into the lateral precordial leads 1.

Alternative Considerations

  • Posterior myocardial infarction - can produce tall R waves in V1-V2 but typically shows dominant R waves (not equal RS) in V5-V6 2
  • Misplaced precordial leads - must be excluded by verifying proper electrode placement 3
  • Dextrocardia - would show progressive decrease in R wave amplitude from V1 to V6 2

Diagnostic Algorithm

Step 1: Verify Technical Accuracy

  • Confirm correct lead placement, particularly that V5 and V6 are at the 5th intercostal space at anterior and mid-axillary lines 3
  • Repeat ECG if placement is uncertain 4

Step 2: Assess QRS Duration and Morphology

  • Measure QRS duration: If ≥120 ms with RSR' in V1-V2, RBBB is present but the RS ratio 1:1 in V5-V6 indicates concurrent right ventricular hypertrophy 1
  • Examine V1-V2: Look for tall R wave with R/S ≥1, which supports RVH 1
  • Check axis: Right axis deviation ≥100° strongly suggests RVH/pulmonary hypertension 1

Step 3: Evaluate for Pulmonary Hypertension

Given the high specificity of this finding for RVH, immediate echocardiography is mandatory to:

  • Assess right ventricular size and function 1
  • Estimate pulmonary artery systolic pressure 1
  • Evaluate for structural heart disease 4

Step 4: Additional Diagnostic Testing

  • Chest radiography to assess for cardiomegaly and pulmonary vascular changes 1
  • Brain natriuretic peptide (BNP) if right heart failure is suspected 1
  • Consider right heart catheterization if echocardiography suggests pulmonary hypertension (mean PA pressure >20 mmHg) 1

Management Approach

Immediate Actions

  • Obtain comprehensive history focusing on:

    • Dyspnea, particularly with exertion 1
    • Syncope or presyncope (ominous signs) 1, 4
    • Risk factors for pulmonary hypertension (connective tissue disease, congenital heart disease, chronic thromboembolic disease, sleep apnea) 1
  • Physical examination should specifically assess for:

    • Loud P2 component of second heart sound (93% sensitive for pulmonary hypertension) 1
    • Right ventricular heave 1
    • Jugular venous distension, hepatomegaly, peripheral edema (indicating right heart failure) 1
    • Low blood pressure and cool extremities (markedly reduced cardiac output - ominous finding) 1

Risk Stratification

Prognostic ECG features that indicate higher mortality risk:

  • P-wave amplitude in lead II ≥0.25 mV (2.8-fold increased death risk) 1
  • Each additional 1 mm P-wave amplitude in lead III (4.5-fold increased death risk) 1

Treatment Considerations

  • If pulmonary hypertension is confirmed, refer urgently to pulmonary hypertension specialist for disease-specific therapy 1
  • If RBBB coexists with RVH, monitor for progression to higher-degree conduction disorders 1, 4
  • Symptomatic patients with syncope require electrophysiology consultation to exclude high-grade AV block 4, 3

Critical Pitfalls to Avoid

  1. Do not dismiss this as "just RBBB" - the RS ratio 1:1 in V5-V6 indicates additional pathology beyond simple conduction delay 1

  2. Do not delay echocardiography - this ECG pattern has 87% sensitivity for right ventricular hypertrophy in pulmonary hypertension patients 1

  3. Recognize that normal ECG does not exclude pulmonary hypertension - 8 of 61 patients with severe PAH (mean PA pressure 50 mmHg) had normal ECGs, but an abnormal pattern like RS 1:1 in V5-V6 is highly specific 1

  4. Consider acute pulmonary embolism - particularly if acute presentation with hemodynamic instability; a QR pattern in V1 with RBBB has high positive predictive value for massive PE causing cardiac arrest 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prominent R wave in lead V1: electrocardiographic differential diagnosis.

The American journal of emergency medicine, 2001

Guideline

Absence of RSR' Pattern in V1-V3: Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of RSR' Pattern in Lead V2 on ECG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.